| Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia V Rocha, M Labopin, G Sanz, W Arcese, R Schwerdtfeger, A Bosi, ... New England Journal of Medicine 351 (22), 2276-2285, 2004 | 1238 | 2004 |
| Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk … C Schmid, M Labopin, A Nagler, M Bornhäuser, J Finke, A Fassas, ... Journal of clinical oncology 25 (31), 4938-4945, 2007 | 556 | 2007 |
| Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older … M Aoudjhane, M Labopin, NC Gorin, A Shimoni, T Ruutu, HJ Kolb, ... Leukemia 19 (12), 2304-2312, 2005 | 519 | 2005 |
| Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow … D Farge, M Labopin, A Tyndall, A Fassas, GL Mancardi, J Van Laar, ... haematologica 95 (2), 284, 2010 | 447 | 2010 |
| A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions A Latouche, A Allignol, J Beyersmann, M Labopin, JP Fine Journal of clinical epidemiology 66 (6), 648-653, 2013 | 436 | 2013 |
| Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation E Gluckman, B Cappelli, F Bernaudin, M Labopin, F Volt, J Carreras, ... Blood, The Journal of the American Society of Hematology 129 (11), 1548-1556, 2017 | 416 | 2017 |
| Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a … S Brunet, M Labopin, J Esteve, J Cornelissen, G Socié, AP Iori, ... Journal of clinical oncology 30 (7), 735-741, 2012 | 360 | 2012 |
| Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation JA Snowden, R Saccardi, M Allez, S Ardizzone, R Arnold, R Cervera, ... Bone marrow transplantation 47 (6), 770-790, 2012 | 342 | 2012 |
| Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019 RF Duarte, M Labopin, P Bader, GW Basak, C Bonini, C Chabannon, ... Bone marrow transplantation 54 (10), 1525-1552, 2019 | 317 | 2019 |
| Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study F Frassoni, F Gualandi, M Podestà, AM Raiola, A Ibatici, G Piaggio, ... The Lancet Oncology 9 (9), 831-839, 2008 | 314 | 2008 |
| Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders C Bellanné-Chantelot, I Chaumarel, M Labopin, F Bellanger, V Barbu, ... Blood 108 (1), 346-352, 2006 | 310 | 2006 |
| A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission … F Ciceri, M Labopin, F Aversa, JM Rowe, D Bunjes, P Lewalle, A Nagler, ... Blood, The Journal of the American Society of Hematology 112 (9), 3574-3581, 2008 | 307 | 2008 |
| Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia O Ringdén, M Labopin, G Ehninger, D Niederwieser, R Olsson, N Basara, ... Journal of Clinical Oncology 27 (27), 4570-4577, 2009 | 299 | 2009 |
| Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation C Schmid, M Labopin, A Nagler, D Niederwieser, L Castagna, R Tabrizi, ... Blood, The Journal of the American Society of Hematology 119 (6), 1599-1606, 2012 | 296 | 2012 |
| Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from … M Mohty, M Labopin, L Volin, A Gratwohl, G Socié, J Esteve, R Tabrizi, ... Blood, The Journal of the American Society of Hematology 116 (22), 4439-4443, 2010 | 278 | 2010 |
| KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia R Willemze, CA Rodrigues, M Labopin, G Sanz, G Michel, G Socie, B Rio, ... Leukemia 23 (3), 492-500, 2009 | 265 | 2009 |
| CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working … M Schmidt-Hieber, M Labopin, D Beelen, L Volin, G Ehninger, J Finke, ... Blood, The Journal of the American Society of Hematology 122 (19), 3359-3364, 2013 | 256 | 2013 |
| Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells NR Mathew, F Baumgartner, L Braun, D O'Sullivan, S Thomas, ... Nature medicine 24 (3), 282-291, 2018 | 254 | 2018 |
| Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved … V Runde, T De Witte, R Arnold, A Gratwohl, J Hermans, A Van Biezen, ... Bone marrow transplantation 21 (3), 255-261, 1998 | 247 | 1998 |
| Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission A Ruggeri, M Labopin, F Ciceri, M Mohty, A Nagler Bone marrow transplantation 51 (4), 610-611, 2016 | 246 | 2016 |
